NCT00593229

International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

An Observational Study of All Forms of Thrombotic Microangiopathy in Pediatric Patients

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 6 (actual)
• Sponsor: Northwell Health · Academic / Other
• Sex: All
• Age: 6 Months – 18 Years
• Healthy volunteers: Accepted

Summary

This registry will collect clinical data and store biosamples (seru, plasma, urine, and DNA) annually from pediatric patients with thrombotic mcroangiopathy

Detailed description

Children age, 6 months - 18 years, are eligible if they have one of the following categories of thrombotic microangiopathy (TMA):(1) severe D+HUS; (2) non-familial atypical HUS; (3) familial atypical HUS; or (4) TTP Patients are seen intially and annually thereafter Biosamples are collected for storage annually.

Conditions

• Thrombotic Microangiopathy
• Hemolytic Uremic Syndrome
• Thrombotic Thrombocytopenic Purpura

Timeline

• Start date: 2007-01-01
• Primary completion: 2011-10-01
• First posted: 2008-01-14
• Last updated: 2013-06-19

Locations

1 site across 1 country: United States